» Articles » PMID: 36741389

Single-cell Analysis of Myeloid Cells in HPV Tonsillar Cancer

Overview
Journal Front Immunol
Date 2023 Feb 6
PMID 36741389
Authors
Affiliations
Soon will be listed here.
Abstract

The incidence of human papillomavirus-positive (HPV) tonsillar cancer has been sharply rising during the last decades. Myeloid cells represent an appropriate therapeutic target due to their proximity to virus-infected tumor cells, and their ability to orchestrate antigen-specific immunity, within the tonsil. However, the interrelationship of steady-state and inflammatory myeloid cell subsets, and their impact on patient survival remains unexplored. Here, we used single-cell RNA-sequencing to map the myeloid compartment in HPV tonsillar cancer. We observed an expansion of the myeloid compartment in HPV tonsillar cancer, accompanied by interferon-induced cellular responses both in dendritic cells (DCs) and monocyte-macrophages. Our analysis unveiled the existence of four DC lineages, two macrophage polarization processes, and their sequential maturation profiles. Within the DC lineages, we described a balance shift in the frequency of progenitor and mature cDC favoring the cDC1 lineage in detriment of cDC2s. Furthermore, we observed that all DC lineages apart from DC5s matured into a common activated DC transcriptional program involving upregulation of interferon-inducible genes. In turn, the monocyte-macrophage lineage was subjected to early monocyte polarization events, which give rise to either interferon-activated or CXCL-producing macrophages, the latter enriched in advanced tumor stages. We validated the existence of most of the single-cell RNA-seq clusters using 26-plex flow cytometry, and described a positive impact of cDC1 and interferon-activated DCs and macrophages on patient survival using gene signature scoring. The current study contributes to the understanding of myeloid ontogeny and dynamics in HPV-driven tonsillar cancer, and highlights myeloid biomarkers that can be used to assess patient prognosis.

Citing Articles

Tumor-infiltrating myeloid cells; mechanisms, functional significance, and targeting in cancer therapy.

Toghraie F, Bayat M, Hosseini M, Ramezani A Cell Oncol (Dordr). 2025; .

PMID: 39998754 DOI: 10.1007/s13402-025-01051-y.


The role of dendritic cells in tertiary lymphoid structures: implications in cancer and autoimmune diseases.

Reste M, Ajazi K, Sayi-Yazgan A, Jankovic R, Bufan B, Brandau S Front Immunol. 2024; 15:1439413.

PMID: 39483484 PMC: 11526390. DOI: 10.3389/fimmu.2024.1439413.

References
1.
Breton G, Zheng S, Valieris R, Tojal Da Silva I, Satija R, Nussenzweig M . Human dendritic cells (DCs) are derived from distinct circulating precursors that are precommitted to become CD1c+ or CD141+ DCs. J Exp Med. 2016; 213(13):2861-2870. PMC: 5154947. DOI: 10.1084/jem.20161135. View

2.
Marie I, Durbin J, Levy D . Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J. 1998; 17(22):6660-9. PMC: 1171011. DOI: 10.1093/emboj/17.22.6660. View

3.
Brown C, Gudjonson H, Pritykin Y, Deep D, Lavallee V, Mendoza A . Transcriptional Basis of Mouse and Human Dendritic Cell Heterogeneity. Cell. 2019; 179(4):846-863.e24. PMC: 6838684. DOI: 10.1016/j.cell.2019.09.035. View

4.
Reynolds G, Vegh P, Fletcher J, Poyner E, Stephenson E, Goh I . Developmental cell programs are co-opted in inflammatory skin disease. Science. 2021; 371(6527). PMC: 7611557. DOI: 10.1126/science.aba6500. View

5.
Angerer P, Haghverdi L, Buttner M, Theis F, Marr C, Buettner F . destiny: diffusion maps for large-scale single-cell data in R. Bioinformatics. 2015; 32(8):1241-3. DOI: 10.1093/bioinformatics/btv715. View